Table 1.
Stage | |
0 | 11 |
I | 58 |
II | 35 |
Nodal status | |
n (−) | 79 |
n (+) | 25 |
Therapy prior to AI administration | |
None | 66 |
TAM | 21 |
CT | 10 |
TAM+LH-RH analogue | 2 |
CT+TAM | 4 |
CT+TAM+LH-RH analogue | 1 |
Stage | |
0 | 11 |
I | 58 |
II | 35 |
Nodal status | |
n (−) | 79 |
n (+) | 25 |
Therapy prior to AI administration | |
None | 66 |
TAM | 21 |
CT | 10 |
TAM+LH-RH analogue | 2 |
CT+TAM | 4 |
CT+TAM+LH-RH analogue | 1 |